Week Ending May 31, 2022

Lung cancer screening awareness is low. How can the industry get the word out?
“Certain cancer screening types, including mammograms and colonoscopies, are well-known among patients. But lung cancer screening isn’t one of them—and even high-risk patients aren’t getting the message.”

Report Examines Imaging Approach With Potential to Detect Lung Cancer at the Cellular Level
“Researchers have found a way to identify lung cancer at the cellular level in real time during a biopsy, which may enable detection of the disease earlier and with more confidence.”

University Of Technology Sydney: Herbal Supplement Shows Promise Against Lung Cancer
“Berberine, a natural compound found in plants such as barberry and goldenseal, supresses the proliferation of lung cancer cells in the lab, new research shows. It also reduces airway inflammation and damage to healthy lung cells exposed to chemicals from cigarette smoke.”

Active Monitoring and Statistical Prediction of Indoor Radon Concentration Can Reduce the Risk of Lung Cancer
“January was National Radon Action Month, a time when the US Environmental Protection Agency (EPA) encourages homeowners to test for and mitigate against the deadly effects of radon gas. While modern radon monitoring devices can detect the presence of the radon with speed and accuracy, reports reveal that too few people take advantage of the technology.”

Mirati drug shrinks tumours in 44% of advanced lung cancer patients
LOS ANGELES (REUTERS) – “An experimental Mirati Therapeutics Inc drug that targets a specific genetic mutation shrank tumours in 44 per cent of advanced lung cancer patients in clinical trials, the company said on Thursday (May 26).”

Lung Cancer Care: How to Improve Quality of Life
“Lung cancer is one of the most common and deadly types of cancer.1 Currently, it is estimated that 541,000 people living in the United States have been diagnosed with lung cancer.2

Perlmutter Cancer Center Medical Oncologist Uses Biomarkers to Treat Lung Cancer
“As cancer researchers make advances in therapies for some of the hardest to treat cancers, matching the right treatment to each patient is becoming more important.”

Black Veterans receive equal, or superior, lung cancer care in VA
“Black Veterans with lung cancer receive comparable care, with equivalent, if not superior, treatment outcomes as white Veterans at VA, according to a study by VA St. Louis researchers. VA cancer care appears to be more equitable than care received in the private sector, where significant racial disparities exist.”

VIDEO: Key lung cancer sessions, networking opportunities to attend at ASCO

VIDEO: Thoracic oncologist highlights key lung cancer studies to watch at ASCO

Trastuzumab Deruxtecan Shows Promising Efficacy for HER2-Mutated NSCLC
“Lyudmila Bazhenova, MD, a medical oncologist and professor of medicine at UC San Diego Health, discusses targeted therapies for patients with HER2-mutated non–small cell lung cancer (NSCLC).”